Direkt-Links zu wichtigen GMP Guidelines

Eudralex Volume 9 Product- or Population-Specific Considerations I: Vaccines for prophylaxis against infectious diseases (EMA/488220/2012)

Impfungen

Mehr

Eudralex Volume 9 Product- or Population-Specific Considerations II: Biological medicinal products

Biological medicinal products

Mehr

Eudralex Volume 9 Product- or Population-Specific Considerations IV: Paediatric population

Particular emphasis on the collection of safety data in the paediatric population, including data on possible long-term effects.

Mehr

GMP Seminare nach Thema